Citeline Commercial’s Post

View organization page for Citeline Commercial, graphic

11,278 followers

Insights from Day Three of the BIO International Convention in San Diego: https://ow.ly/IrAp50SkhrX. Included in this installment of Scrip’s daily notebook of noteworthy intelligence from the BIO International Convention: • Amgen CEO Bob Bradway taking aim at the "Innovation Reduction Act" • Novo Nordisk's business development head discussing spending its semaglutide bounty • Roivant Sciences's long view on BD prospects for Immunovant's FcRn inhibitor • More regulatory concerns around artificial intelligence #ArtificialIntelligence #InnovationReductionAct #Pharma #Biotech #BIOInternationalConvention

BIO Notebook: Amgen CEO Blasts IRA, Novo Nordisk Stays Cautious On BD, And More

BIO Notebook: Amgen CEO Blasts IRA, Novo Nordisk Stays Cautious On BD, And More

To view or add a comment, sign in

Explore topics